Health Canada
- Status: approved
🇨🇦 Dual antithrombotic therapy with NOAC and clopidogrel in Canada
Dual antithrombotic therapy with NOAC and clopidogrel (Dual antithrombotic therapy with NOAC and clopidogrel) regulatory status in Canada.
Marketing authorisation
Dual antithrombotic therapy with NOAC and clopidogrel in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Dual antithrombotic therapy with NOAC and clopidogrel approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for Dual antithrombotic therapy with NOAC and clopidogrel in Canada?
Yonsei University is the originator. The local marketing authorisation holder may differ — check the official source linked above.